[1]
R. Liubota et al., “Metformin in neoadjuvant systemic therapy of breast cancer patients with metabolic syndrome”, Arch Oncol, vol. 24, no. 1, pp. 1–5, July 2018, doi: 10.2298/AOO180312003L.